Corrigendum to "Degradation of NLRP3 by selective ROCK2 inhibitor alleviates acute lung injury" [Eur. J. Pharmacol. 1004 (2025) 178009].

Documenti analoghi

• Degradation of NLRP3 by selective ROCK2 inhibitor alleviates acute lung injury.
  di: Zhan, Shuai, et al.
  Pubblicazione: (2025)
• KHSRP protects colorectal cancer cells against ferroptosis by regulating GPX4 expression through interaction with hnRNPM.
  di: Ding, Xia, et al.
  Pubblicazione: (2025)
• Discovery of the First-in-Class Dual-Target ROCK/HDAC Inhibitor with Potent Antitumor Efficacy in Vivo That Trigger Antitumor Immunity.
  di: Mao, Churu, et al.
  Pubblicazione: (2024)
• Discovery of an orally bioavailable pyridone-based BRD4 inhibitor with potent antitumor efficacy in colorectal cancer.
  di: Fang, Zhangyun, et al.
  Pubblicazione: (2026)
• Design, Synthesis, and Evaluation of a Potent and Selective ROCK2 Inhibitor for Atopic Dermatitis Treatment.
  di: Mao, Churu, et al.
  Pubblicazione: (2026)